Smartphone intervention for pregnancy smoking cessation with peer support: the study protocol of the SmokeFree Together 2.0 (SFT 2.0) randomised controlled trial

    Introduction Smoking in pregnancy negatively impacts the mother’s and offspring’s health. Mobile health, especially mobile phone-based approaches, shows promise in supporting pregnant women to quit smoking. Our previous research indicated that support from laypersons, such as family, friends and coworkers, can increase smoking cessation. Building on these findings, we developed an innovative smartphone application (app) that combines the power of social support with artificial intelligence. The app leverages the unique functionality of smartphones and reinforcement learning (RL) to provide a deeply tailored intervention that continuously adapts while emphasising positive support through reciprocal interactions between the smoker and the support person. Herein, we report the methods used to develop, implement and test the feasibility and effectiveness of a novel adaptive mobile pregnancy tobacco cessation app-based intervention using deep tailoring and a self-nominated supporter.

    Methods and analysis The study is a type II hybrid effectiveness-implementation randomised controlled trial. In total, 300 pregnant smokers and their supporters will be randomised to (1) the SmokeFree Together 2.0 app and an RL-based intervention that continuously decides if a counselling call is needed using a fixed algorithm measuring motivation and craving or (2) a control group. The intervention will be administered throughout pregnancy up to 1 month after giving birth, with a 5-month follow-up period and outcome assessments at 3-month and 6-month post partum. Cessation (primary outcome) is defined as 7-day point biochemically verified prevalence of tobacco use and abstinence since birth, assessed at 6 months post partum. The central hypothesis is that the intervention will show evidence of feasibility and effectiveness in increasing social support, pregnancy cessation and postnatal abstinence.

    Ethics and dissemination The Institutional Review Board of Michigan State University (#IRB00000297) approved this trial. The findings will be disseminated through peer-reviewed publications and participation in scientific conferences.

    Trial registration number NCT05337722. Protocol version: 1.3 from 15.05.2024.

    http://creativecommons.org/licenses/by-nc/4.0/

    This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Tobacco remains the leading global cause of preventable disease and death, killing more than 8 million people a year around the world.1 Tobacco smoking among women in Romania increased dramatically by close to 30% between 2011 and 2018, and the share of smokers with quit attempts decreased by 37% during this period.1 Smoking among reproductive-aged women is especially harmful because, in addition to its effects on the smoker’s mortality and morbidity, it negatively impacts pregnancy,2 3 birth4 and the health of the offspring.5 6 In Romania, 50% of women smokers continue during pregnancy, and most experience moderate-to-high nicotine dependence,7 with no improvement in the past decade.8 9 Nearly 60% of those who quit during pregnancy relapsed post partum.

    Access to tobacco cessation services in Romania is limited, including services for pregnant smokers. There is no automatic referral of pregnant smokers to a quitline or a cessation programme. Many pregnant smokers in Romania are not asked about smoking, are not counselled to quit and receive mixed information from their primary care physician (PCP)10 or obstetrics-gynaecology (OB-GYN) regarding the benefits of quitting smoking.11 Some providers advise against cessation, arguing that quitting may stress the fetus and that smoking a few cigarettes a day during pregnancy is acceptable.10 Nonetheless, most pregnant smokers understand the benefits of quitting and want to stop smoking.10 Research suggests that support from laypersons, including relatives, friends, coworkers or partners, may encourage cessation and abstinence.12 There is relatively little research on the role of social support in quitting smoking during pregnancy, and the available data have shown limited success,12 most likely because eliciting effective support proved difficult. Similar to pregnancy-specific studies, most general population interventions that assessed peer or partner support showed that the interventions did not actually increase the support for cessation.12

    The potential of mobile health, especially mobile phone-based strategies, to increase the effectiveness and reach of behaviour change interventions is enormous, given the large and expanding smartphone ownership.13 Even in resource-constrained countries, mobile phone ownership is very high. In Romania, a low- and middle-income country at the start of this study, the smartphone penetration rate was close to 70% in 2017.14 Applications (apps) leverage the unique functionality of smartphones to deliver messages and content deeply tailored using momentary assessments, including readiness to quit, cravings, stress and need for support.15 To our knowledge, there is only one large-scale tested pregnancy-specific app for smoking cessation16 17 and no tested app for smoking cessation with lay support in pregnancy nor in the general population.18

    This manuscript presents the protocol of the Smoke-Free Together 2.0 (SFT2.0), a type II hybrid effectiveness implementation randomised controlled trial (RCT) targeting tobacco smokers during pregnancy and the first month post partum. The RCT evaluates a user-centred, artificial intelligence-driven mobile app for tobacco cessation during pregnancy. The app features deep tailoring of messages and the inclusion of a self-nominated support person to enhance social support. The intervention is grounded in self-determination theory (SDT)19–21 and uses motivational interviewing (MI),22–24 a counselling style that is effective in assisting people to quit smoking. The central hypothesis is that the intervention will show evidence of feasibility and effectiveness in increasing social support, pregnancy smoking cessation and postnatal abstinence, while achieving these outcomes more efficiently through reinforcement learning that optimises the delivery of MI counselling sessions.

    The development and testing of the SFT 2.0 app was conducted through NIH’s R21/R33 mechanism, where the R21 phase supported the development and pilot testing of the app and the R33 funding allows for the implementation and evaluation through an RCT (#R21HD103039 and #R33HD103039 to CIM and KF). This RCT is a hybrid effectiveness implementation trial25 in which the SFT2.0 app-based smoking cessation intervention will be tested among 300 Romanian pregnant smokers and their support persons. Participants will be randomised into two groups: (1) an RL arm, where the SFT2.0 app will be provided to the pregnant woman and her support person, will continuously determine if MI counselling sessions are needed or (2) a control group that will receive a one-page leaflet on the effects of smoking during pregnancy and the importance of quitting. In Romania, the latter is considered usual care. Hybrid designs offer an opportunity to simultaneously test the effectiveness and implementation of innovations intended to close the gap between the availability of evidence-based interventions (eg, smoking cessation support) and their uptake among vulnerable populations. The intervention will be administered throughout pregnancy up to 1 month after giving birth, with a 5-month follow-up period and outcome assessments at 3-month and 6-month post partum.

    The study process and the timeline for enrolment, intervention participation and assessments are shown in figure 1.

    Figure 1

    Figure 1

    Study process and timeline for enrolment, intervention participation and assessments. ads, advertisements; GDPR, General Data Protection Regulation; MI, motivational interviewing; RL, reinforcement learning; SFT 2.0, Smoke-Free Together 2.0.

    The study is being conducted across Romania and began in January 2023; the estimated completion date is August 2025.

    Participants are Romanian-speaking pregnant women who smoke in any amount, up to 32+ weeks of gestation, who are 18 or older (the legal adult and tobacco use age in Romania), who own an Android smartphone with broadband data access (Android represents approximately 90% of the smartphone market in Romania) and can nominate a support person to assist with smoking cessation and abstinence maintenance. Support persons must be Romanian speakers, 18 or older and own an Android smartphone with broadband data access.

    Recruitment occurs through two pathways: (1) online social media advertisements and (2) referrals from medical professionals throughout Romania, building on partnerships established with OB-GYN clinics in the R21 phase and a continuously growing network of health ambassadors (PCP, community health nurses, prenatal educators, etc). Health ambassadors are health professionals who work with pregnant women and agree to volunteer to disseminate information about the project and support enrolment.

    The social media recruitment strategy employs multiple platforms, including Facebook, Instagram and TikTok. This approach combines continuous monthly paid campaigns on Facebook and Instagram with regular sharing of educational content pertinent to pregnant women (ie, regular check-ups recommended during pregnancy and their timeline). The project team also organises periodic giveaways of maternity accessories, such as maternity bags or pillows, to boost enrolment and engagement with the project’s social media pages.

    Participants referred through healthcare professionals find out about the project during routine clinical visits when healthcare providers briefly present it to eligible pregnant smokers and offer them a card with the project details, including the link to the dedicated project website.

    Both recruitment pathways direct participants to the dedicated project website that hosts the description of the project, information about the team and funding and the link to a Qualtrics form where women and support persons can self-assess their eligibility. Eligible subjects are presented with the study’s informed consent form (sample available as online supplemental file 1), the General Data Protection Regulation (GDPR) form and the baseline RCT survey. On completion of the survey, both women and support persons can download a one-page leaflet describing the effects of smoking during pregnancy and the importance of quitting.

    Pairs of pregnant women and their support persons were randomised in equal numbers to two intervention arms using blocked randomisation with randomly selected block sizes (block sizes of 2, 4 and 6).26 This method was chosen to balance participant allocation across the two RCT arms. The randomisation was done using computer software (www.randomization.com) incorporating a random number generator. Group allocation at study entry is concealed. While not practical to mask participants beyond enrolment and the MI counsellors, the outcome assessor will be masked to group allocation. The risk of contamination of the control group is low as there is no other pregnancy smoking cessation app available in Romania. We will measure the use of other cessation programmes during pregnancy and account for their use in the analyses.

    Intervention group

    The trial’s intervention consists of two components: (1) the SFT 2.0 app, which has two interconnected versions, one for pregnant smokers and one for their nominated support person, and (2) up to 10 MI counselling sessions delivered via video calls by trained counsellors and supervised by MI experts for treatment fidelity. Participants can use the app continuously from their enrolment during pregnancy up to 1 month post partum and access personalised content based on an in-app assessment of their reasons for smoking, motivators for quitting, values, barriers to quitting and staying smoke-free, and smoking triggers. The user’s selection feeds the content of the smoking cessation guide (why quit, how to quit, how to reduce relapse and how to maintain mental health) available in the app. The pregnant woman’s version of the app delivers deeply tailored content aimed at enhancing motivation to quit (including a calculated number of cigarettes not smoked and money saved since quitting) and facilitating quit date setting. The tailoring system responds to real-time user assessments of mood, smoking urges and support needs.

    The pregnant woman’s version includes specific prompts for requesting assistance, while the supporter’s version provides guidance on offering both proactive and reactive cessation support. The app facilitates direct interaction between the smoker and supporter through built-in communication features. Throughout pregnancy, the app maintains user engagement through weekly push notifications containing pregnancy week-specific updates on baby development and one weekly assessment of the smoking status. Women report their smoking status (smoker/quit). Current smokers rate their importance, willingness and confidence to quit on a 10-point scale. Those who have quit rate their importance and confidence to stay quit, plus cravings and depression levels.

    Based on the user’s response to the weekly smoking status assessment push notification, the app uses an algorithm to determine if the participant is assigned an MI counselling session that week. One algorithm is based on the motivation for the smoker to quit, and the second algorithm is based on relapse risk for smokers who have quit. Participants are asked about importance, confidence and readiness to quit using a 0–10 scale, and those scoring below 7 on any of these items are offered counselling; for quitters, we assess confidence to stay quit, stress, craving and depression using a 1–10 scale, where confidence to stay quit <7, and scores ≥7 on stress, craving or depression indicate relapse risk, prompting an MI session.

    The MI component is delivered via smartphone by trained counsellors who participated in 100+ hours of face-to-face and online practical MI training. The interactive training focused on the principles and strategies of MI including supporting autonomy, rolling with resistance and evoking change talk. Key strategies included reflective listening, importance/confidence rulers and values linkage.27 28 The training was conducted in English by author KR with the assistance of study staff. Quarterly booster sessions were offered remotely or in person.

    To ensure treatment fidelity, all counselling sessions are recorded and selectively coded using a practical easy-to-use tool for assessing practitioner skills in MI entitled OnePass coding system.29 The MI supervisor continuously assesses adherence to MI by coding audio-recorded counselling sessions. To date, 53 counselling sessions (out of 239 available sessions) have been coded using the OnePass tool. Assessments on OnePass can range from 1 (poor/never) to 7 (excellent/always), and a score of 5 is considered minimal competence. Out of the 53 MI counselling sessions evaluated, 16 had a mean score below 5. Based on two independent coders of OnePass scores of 16 counselling sessions (30% out of the total number of coded sessions), an excellent degree of reliability was found between the OnePass assessments of the two independent coders. The average measure ICC was 0.906 with a 95% CI from 0.731 to 0.967 (F(15,15)= 10.651, p=0.000).

    Control group

    The participants in the control group receive an electronic one-page leaflet with information on the effects of smoking during pregnancy and the benefits of quitting and remaining smoke-free.

    Effectiveness outcomes

    Primary and secondary effectiveness outcomes are assessed at 3 and 6 months post partum through online Qualtrics questionnaires distributed via text messages. The primary outcomes include 7-day point abstinence and sustained abstinence (1, 3 and 6 months postbirth). Secondary effectiveness outcomes include quit attempts and the number of cigarettes smoked per day after the intervention. Biochemical verification is required from participants who self-report 7-day point abstinence during a brief telephone survey at the 6-month assessment. Participants who self-report as non-smokers receive a NarcoCheck instant saliva test kit by mail. The test administration is conducted under telephone guidance from a member of the research team. While waiting 10 min for the results, the researcher administers the 6-month follow-up questionnaire to the woman. After the waiting time has finished, participants are required to send one photo of the test showing the results. Support persons complete a separate follow-up assessment at 6 months post partum. Their online questionnaire, distributed via text message, collects data on the level of cessation support provided to the pregnant participant and their satisfaction with the SFT 2.0 app. For non-respondents to the online questionnaires, research staff conducted telephone follow-ups using the same version of the two questionnaires.

    Implementation outcomes

    Reach will be measured as the proportion and representativeness (eg, age, marital status, ethnicity) of dyads who enrol in each trial arm compared with each other and the general population of pregnant women in Romania. These data will be collected via self-report among all participants at baseline. Adoption will be measured as the proportion of participants who enrol in SFT by recruitment strategy (via clinics, social media and health ambassadors). User engagement will be measured by participants’ frequency of overall SFT 2.0 app use and frequency of use of counselling sessions. This will be assessed through overall use of the intervention (eg, composite measure of app use and MI counselling sessions), app engagement measures (number and frequency of app sessions, duration in app, number of app components used) and number of MI video counselling sessions, which the MI counsellor will document in the project’s database.

    App engagement is tracked within the SFT 2.0 app and collected throughout the intervention delivery. Metrics include the number and frequency of app sessions and the duration of time spent in the app for each user. The 6-month follow-up survey also assesses the general satisfaction with programme participation on a 5-point Likert scale (very dissatisfied to very satisfied), the app usability using the system usability scale (SUS) comprising 11 items rated on a 5-point Likert scale (strongly disagree to strongly agree) and satisfaction level with the MI sessions for the participants who engaged in counselling sessions.30

    All assessments per pregnant woman and support person are listed in table 1 (participant timeline).

    Table 1

    Measurement of the effectiveness and implementation outcomes of the SFT 2.0 type II hybrid effectiveness implementation trial to test a mobile app to reduce smoking during pregnancy

    We planned for a sample of 300 subjects (150 per intervention group), based on our own preliminary findings and recruitment feasibility considerations driven by our prior pilot data with the same target population and the significant budget reductions by the funding agency for the R33 phase of the project. This sample size, taking into account <20% follow-up attrition, would allow the identification of quit rate differences as little as a 10% absolute difference by treatment arm (eg, 30% vs 20%) between the intervention arm and the control group, with 80% power and p<0.05 statistical significance. Such an effect size would be in line with our preliminary efficacy findings in a pilot trial in the same target population of pregnant smokers in Romania.

    Effectiveness outcomes

    We will employ intent-to-treat techniques for all analyses with those lost to follow-up considered smokers. To test our primary treatment effect hypotheses, we will employ multivariate analyses, including random effects regression models (subject-specific effects) and the method of generalised estimating equations (population-averaged effects, fewer assumptions), modelled including the effect of time within participants. We will report crude and covariate-adjusted estimates from both models. All multivariate analyses will include an indicator for participation in cessation/abstinence treatment to account for contamination. We will also perform effectiveness sensitivity analyses, excluding the possible contaminated cases, if any. All hypothesis tests will be two-sided (p≤0.05). With a primary assumption of ‘missing at random’, we will use multiple imputations for missing data. If biochemical verification of smoking status fails or is missing, non-smoker self-reported subjects will be coded as smokers at the 6-month follow-up.

    Implementation outcomes

    We will calculate reach by comparing the demographic characteristics of enrolled dyads to the general population of pregnant women in Romania using χ2 tests for categorical variables and t-tests for continuous variables. For adoption, we will analyse the proportion of enrolled participants by recruitment pathway (clinics, social media, health ambassadors) using descriptive statistics.

    User engagement metrics will be examined both as individual measures and as composite scores. We will track the number of app sessions, duration of use and interaction with specific app components. For participants receiving MI counselling, we will analyse the number and timing of sessions. Descriptive statistics will characterise patterns of engagement over time, with particular attention to potential drop-offs in usage. We will employ linear mixed models to examine whether engagement varies by participant characteristics or recruitment pathway. For app engagement specifically, we will analyse the app metrics data to identify usage patterns and potential predictors of sustained engagement. The analysis will include examining correlations between engagement metrics and smoking-related outcomes. The SUS scores will be analysed following standard scoring procedures.30

    Patient and public involvement has been an instrumental part of the development of the SFT 2.0 smartphone app. During the R21 phase, the research team conducted research to inform the app content, design, usability and intervention features as follows: in-depth interviews with five pregnant women who smoked and their support persons in the formative research phase, 12 unmoderated and 6 moderated usability testing sessions with pregnant smokers and support persons in the usability testing phase of the SFT 2.0 app and a 12-week open pilot trial with 20 pregnant smokers and their 20 nominated support persons. This open trial aimed to test the feasibility and acceptability of the SFT2.0 app-based intervention and MI video counselling before the full-scale trial.

    Healthcare providers, including gynaecologists, PCP, community health mediators and prenatal educators, were also engaged in establishing recruitment partnerships. To maintain the ongoing engagement of healthcare providers, the project set up an ambassador programme recognising healthcare providers who actively and voluntarily support the dissemination of trial-related information to support enrolment.

    In addition, the trial benefits from the guidance of an External Advisory Board chaired by a senior public health expert who brings together key stakeholders in Romanian maternal and tobacco control. Board membership includes practising OB-GYN specialists who provide direct patient care, former leadership from the national STOP SMOKING tobacco cessation programme, the director of Romania’s national ‘2035 Tobacco Free’ initiative and representatives from SAMAS, a non-governmental organisation focused on maternal health. This diverse composition ensures the trial benefits from clinical, public health, tobacco control policy and community perspectives. The Board provides strategic guidance on recruitment strategies, implementation approaches and potential pathways for scaling up and sustaining the intervention within the Romanian healthcare system after the trial period.

    This trial is now recruiting participants. The trial was registered on ClinicalTrials.gov (NCT05337722) prior to participant enrolment.

    The study protocol and all study-related materials received ethical approval from Michigan State University Institutional Review Board (IRB). Before study enrolment, all participants provide electronic informed consent through the secure Qualtrics platform. Additionally, participants complete GDPR consent forms as required by European Union data protection regulations. Protocol modifications are documented as amendments and validated by the Michigan State University IRB.

    The intervention is delivered by counsellors trained in MI techniques for smoking cessation. To ensure intervention quality, counsellors receive ongoing supervision and participate in regular team meetings to discuss complex cases. Their sessions are also coded for fidelity to MI. For participants identified with serious mental health conditions, referral protocols are in place to connect them with certified psychotherapists while maintaining their study participation when appropriate.

    Trial findings will be disseminated to participants through a plain-language summary and to the broader Romanian medical community through our healthcare provider network.

    All data in this trial will be collected through the secured Health Insurance Portability and Accountability Act-compliant and GDPR-compliant Qualtrics platform.31 Data management will include data accuracy checks, outlier examination, missing data patterns, distributional assumptions and the intervention/control balance at baseline. The trial is overseen by an independent Data Safety Monitoring Board (DSMB) established at Babes-Bolyai University, consisting of a biostatistician, a health systems expert and a public health expert. The DSMB reviews yearly enrolment data, individual adverse events, baseline characteristics, data quality, recruitment and retention rates, protocol adherence and factors that might affect study outcomes.

    Tobacco use remains a leading global cause of preventable disease and death,32 with significant challenges in cessation, particularly among pregnant women.33 34 App-based interventions to promote quitting during pregnancy are scarce, with mixed findings.17 While counselling has been shown to be effective, it can be costly in developing economies, thus strategies to employ counselling more judiciously are needed. This RCT introduces an innovative approach to addressing smoking cessation during pregnancy that leverages smartphone technology, peer support and reinforcement learning to determine when counselling calls are employed.

    The SFT 2.0 intervention goes beyond the state-of-the-art pregnancy smoking cessation interventions as: (1) it expands the breadth of supporters to any lay person (eg, family, relative, friend, coworker, spouse) nominated by the pregnant smoker; (2) it adds deep tailoring and reinforcement learning to adapt the intervention continuously; (3) it uses formative data from the target population to increase engagement with the intervention; (4) it shifts current approaches by building implementation and cost considerations into intervention development and study design in a hybrid trial approach; and (5) the intervention’s theoretical foundation in SDT and MI provides a robust conceptual framework.

    These innovative features directly inform the study’s methodological approach. The hybrid effectiveness and implementation design are particularly noteworthy. Unlike traditional RCTs, this approach allows for simultaneous evaluation of intervention effectiveness and implementation strategies to better understand how to optimise and accelerate the translation of the SFT2.0 app-based intervention into practice.35

    On successful completion of the RCT, we expect a feasible and acceptable app-based pregnancy smoking cessation intervention with lay support that is effective in increasing cessation and abstinence. This will be significant because it will provide strong evidence of lay support’s effectiveness in using smartphones’ functionalities to increase smoking cessation. In addition, this research has broader implications beyond immediate tobacco cessation, including a wide range of public health interventions potentially relevant to all women of reproductive age, including nutrition, physical activity and childcare. It demonstrates a potential model for developing user-centred, technology-driven health interventions that can be adapted to various behavioural health challenges. The approach could be particularly valuable in low- and middle-income countries with limited healthcare resources.

    Several limitations should be acknowledged. First, the context-specific nature of the study, focused on Romania, may limit the generalisability of the findings. There may be unique cultural and systemic factors that limit generalisability even to other Eastern European cultures. Second, the reliance on smartphone technology, broadband internet access and Android-operated devices could induce access barriers for some users.

    Our rules-based RL system used a fixed algorithm based on motivation to quit and risk of relapse for quitters measured every week to assign who gets a counselling call. The goal is to increase the efficiency of counselling resources by targeting those who need it the most. More sophisticated RL systems can learn and adapt the allocation algorithms based on how they impact short-term functions (eg, motivation), and they can be tailored to user characteristics (eg, age, baseline smoking).36 37 Time and budget reductions precluded the use of a more adaptive ‘living’ RL intervention.

    In summary, given the impact of tobacco use during pregnancy and the limited effectiveness of current interventions, this trial will provide evidence on the feasibility and effectiveness of a novel, user-centred mobile app, using basic reinforcement learning, for pregnancy tobacco cessation that leverages lay support, deep tailoring, and adaptive MI counselling to increase positive support, pregnancy cessation and postnatal abstinence.

    Not applicable.

    We are grateful to our participants and the healthcare partners throughout Romania, including gynaecologists, primary care physician, community health mediators and prenatal educators who support participant recruitment. We especially acknowledge our programme ambassadors for their efforts in disseminating the project.

    Read the full text or download the PDF: